DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Colao A, Pivonello R, Auriemma RS, De Martino MC, Bidlingmaier M, Briganti F, Tortora F, Burman P, Kourides IA, Strasburger CJ, Lombardi G.
Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance.
Eur J Endocrinol 2006; 154: 467-477
We do not assume any responsibility for the contents of the web pages of other providers.